Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.
The global Bronchodilators market is projected to grow from US$ 32680 million in 2023 to US$ 42270 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.
Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.
Report Includes:
This report presents an overview of global market for Bronchodilators, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Bronchodilators, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bronchodilators, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bronchodilators sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Bronchodilators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Bronchodilators sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and F. Hoffmann-La Roche, etc.
By Company
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
F. Hoffmann-La Roche
Segment by Type
Anticholinergic Bronchodilators
Adrenergic Bronchodilators
Bronchodilator Combinations
Methylxanthines
Segment by Application
Asthma
COPD
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Bronchodilators in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Bronchodilators manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bronchodilators sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Bronchodilators Product Introduction
1.2 Market by Type
1.2.1 Global Bronchodilators Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Anticholinergic Bronchodilators
1.2.3 Adrenergic Bronchodilators
1.2.4 Bronchodilator Combinations
1.2.5 Methylxanthines
1.3 Market by Application
1.3.1 Global Bronchodilators Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bronchodilators Sales Estimates and Forecasts 2018-2029
2.2 Global Bronchodilators Revenue by Region
2.2.1 Global Bronchodilators Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Bronchodilators Revenue by Region (2018-2023)
2.2.3 Global Bronchodilators Revenue by Region (2024-2029)
2.2.4 Global Bronchodilators Revenue Market Share by Region (2018-2029)
2.3 Global Bronchodilators Sales Estimates and Forecasts 2018-2029
2.4 Global Bronchodilators Sales by Region
2.4.1 Global Bronchodilators Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Bronchodilators Sales by Region (2018-2023)
2.4.3 Global Bronchodilators Sales by Region (2024-2029)
2.4.4 Global Bronchodilators Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Bronchodilators Sales by Manufacturers
3.1.1 Global Bronchodilators Sales by Manufacturers (2018-2023)
3.1.2 Global Bronchodilators Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bronchodilators in 2022
3.2 Global Bronchodilators Revenue by Manufacturers
3.2.1 Global Bronchodilators Revenue by Manufacturers (2018-2023)
3.2.2 Global Bronchodilators Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Bronchodilators Revenue in 2022
3.3 Global Key Players of Bronchodilators, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Bronchodilators Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bronchodilators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bronchodilators, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bronchodilators, Product Offered and Application
3.8 Global Key Manufacturers of Bronchodilators, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bronchodilators Sales by Type
4.1.1 Global Bronchodilators Historical Sales by Type (2018-2023)
4.1.2 Global Bronchodilators Forecasted Sales by Type (2024-2029)
4.1.3 Global Bronchodilators Sales Market Share by Type (2018-2029)
4.2 Global Bronchodilators Revenue by Type
4.2.1 Global Bronchodilators Historical Revenue by Type (2018-2023)
4.2.2 Global Bronchodilators Forecasted Revenue by Type (2024-2029)
4.2.3 Global Bronchodilators Revenue Market Share by Type (2018-2029)
4.3 Global Bronchodilators Price by Type
4.3.1 Global Bronchodilators Price by Type (2018-2023)
4.3.2 Global Bronchodilators Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Bronchodilators Sales by Application
5.1.1 Global Bronchodilators Historical Sales by Application (2018-2023)
5.1.2 Global Bronchodilators Forecasted Sales by Application (2024-2029)
5.1.3 Global Bronchodilators Sales Market Share by Application (2018-2029)
5.2 Global Bronchodilators Revenue by Application
5.2.1 Global Bronchodilators Historical Revenue by Application (2018-2023)
5.2.2 Global Bronchodilators Forecasted Revenue by Application (2024-2029)
5.2.3 Global Bronchodilators Revenue Market Share by Application (2018-2029)
5.3 Global Bronchodilators Price by Application
5.3.1 Global Bronchodilators Price by Application (2018-2023)
5.3.2 Global Bronchodilators Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Bronchodilators Market Size by Type
6.1.1 US & Canada Bronchodilators Sales by Type (2018-2029)
6.1.2 US & Canada Bronchodilators Revenue by Type (2018-2029)
6.2 US & Canada Bronchodilators Market Size by Application
6.2.1 US & Canada Bronchodilators Sales by Application (2018-2029)
6.2.2 US & Canada Bronchodilators Revenue by Application (2018-2029)
6.3 US & Canada Bronchodilators Market Size by Country
6.3.1 US & Canada Bronchodilators Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Bronchodilators Sales by Country (2018-2029)
6.3.3 US & Canada Bronchodilators Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Bronchodilators Market Size by Type
7.1.1 Europe Bronchodilators Sales by Type (2018-2029)
7.1.2 Europe Bronchodilators Revenue by Type (2018-2029)
7.2 Europe Bronchodilators Market Size by Application
7.2.1 Europe Bronchodilators Sales by Application (2018-2029)
7.2.2 Europe Bronchodilators Revenue by Application (2018-2029)
7.3 Europe Bronchodilators Market Size by Country
7.3.1 Europe Bronchodilators Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Bronchodilators Sales by Country (2018-2029)
7.3.3 Europe Bronchodilators Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Bronchodilators Market Size
8.1.1 China Bronchodilators Sales (2018-2029)
8.1.2 China Bronchodilators Revenue (2018-2029)
8.2 China Bronchodilators Market Size by Application
8.2.1 China Bronchodilators Sales by Application (2018-2029)
8.2.2 China Bronchodilators Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bronchodilators Market Size by Type
9.1.1 Asia Bronchodilators Sales by Type (2018-2029)
9.1.2 Asia Bronchodilators Revenue by Type (2018-2029)
9.2 Asia Bronchodilators Market Size by Application
9.2.1 Asia Bronchodilators Sales by Application (2018-2029)
9.2.2 Asia Bronchodilators Revenue by Application (2018-2029)
9.3 Asia Bronchodilators Sales by Region
9.3.1 Asia Bronchodilators Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Bronchodilators Revenue by Region (2018-2029)
9.3.3 Asia Bronchodilators Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bronchodilators Market Size by Type
10.1.1 Middle East, Africa and Latin America Bronchodilators Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Bronchodilators Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Bronchodilators Market Size by Application
10.2.1 Middle East, Africa and Latin America Bronchodilators Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Bronchodilators Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Bronchodilators Sales by Country
10.3.1 Middle East, Africa and Latin America Bronchodilators Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Bronchodilators Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Bronchodilators Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Bronchodilators Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 AstraZeneca Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Bronchodilators Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Boehringer Ingelheim Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Bronchodilators Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 GlaxoSmithKline Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Information
11.4.2 F. Hoffmann-La Roche Overview
11.4.3 F. Hoffmann-La Roche Bronchodilators Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 F. Hoffmann-La Roche Bronchodilators Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 F. Hoffmann-La Roche Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bronchodilators Industry Chain Analysis
12.2 Bronchodilators Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bronchodilators Production Mode & Process
12.4 Bronchodilators Sales and Marketing
12.4.1 Bronchodilators Sales Channels
12.4.2 Bronchodilators Distributors
12.5 Bronchodilators Customers
13 Market Dynamics
13.1 Bronchodilators Industry Trends
13.2 Bronchodilators Market Drivers
13.3 Bronchodilators Market Challenges
13.4 Bronchodilators Market Restraints
14 Key Findings in The Global Bronchodilators Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
F. Hoffmann-La Roche
听
听
*If Applicable.